Global Multivalent Pneumococcal Conjugate Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 96

Published Date: 05 May 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Multivalent Pneumococcal Conjugate Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Multivalent Pneumococcal Conjugate Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Multivalent Pneumococcal Conjugate Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multivalent Pneumococcal Conjugate Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Multivalent Pneumococcal Conjugate Vaccine total production and demand, 2018-2029, (K Units)
Global Multivalent Pneumococcal Conjugate Vaccine total production value, 2018-2029, (USD Million)
Global Multivalent Pneumococcal Conjugate Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Multivalent Pneumococcal Conjugate Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Multivalent Pneumococcal Conjugate Vaccine domestic production, consumption, key domestic manufacturers and share
Global Multivalent Pneumococcal Conjugate Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Multivalent Pneumococcal Conjugate Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Multivalent Pneumococcal Conjugate Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Multivalent Pneumococcal Conjugate Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Sharp & Dohme Corp, Pfizer, CanSino Bio, Serum Institute of India Pvt. Ltd. and Shanghai Weizhou Biotechnology Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Multivalent Pneumococcal Conjugate Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Multivalent Pneumococcal Conjugate Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Multivalent Pneumococcal Conjugate Vaccine Market, Segmentation by Type
13 Price
20 Price
23 Price
24 Price

Global Multivalent Pneumococcal Conjugate Vaccine Market, Segmentation by Application
Hospital
Outpatient Center
Others

Companies Profiled:
Merck Sharp & Dohme Corp
Pfizer
CanSino Bio
Serum Institute of India Pvt. Ltd.
Shanghai Weizhou Biotechnology Co., Ltd.

Key Questions Answered
1. How big is the global Multivalent Pneumococcal Conjugate Vaccine market?
2. What is the demand of the global Multivalent Pneumococcal Conjugate Vaccine market?
3. What is the year over year growth of the global Multivalent Pneumococcal Conjugate Vaccine market?
4. What is the production and production value of the global Multivalent Pneumococcal Conjugate Vaccine market?
5. Who are the key producers in the global Multivalent Pneumococcal Conjugate Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Multivalent Pneumococcal Conjugate Vaccine Introduction
    1.2 World Multivalent Pneumococcal Conjugate Vaccine Supply & Forecast
        1.2.1 World Multivalent Pneumococcal Conjugate Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Multivalent Pneumococcal Conjugate Vaccine Production (2018-2029)
        1.2.3 World Multivalent Pneumococcal Conjugate Vaccine Pricing Trends (2018-2029)
    1.3 World Multivalent Pneumococcal Conjugate Vaccine Production by Region (Based on Production Site)
        1.3.1 World Multivalent Pneumococcal Conjugate Vaccine Production Value by Region (2018-2029)
        1.3.2 World Multivalent Pneumococcal Conjugate Vaccine Production by Region (2018-2029)
        1.3.3 World Multivalent Pneumococcal Conjugate Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Multivalent Pneumococcal Conjugate Vaccine Production (2018-2029)
        1.3.5 Europe Multivalent Pneumococcal Conjugate Vaccine Production (2018-2029)
        1.3.6 China Multivalent Pneumococcal Conjugate Vaccine Production (2018-2029)
        1.3.7 Japan Multivalent Pneumococcal Conjugate Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Multivalent Pneumococcal Conjugate Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Multivalent Pneumococcal Conjugate Vaccine Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Multivalent Pneumococcal Conjugate Vaccine Demand (2018-2029)
    2.2 World Multivalent Pneumococcal Conjugate Vaccine Consumption by Region
        2.2.1 World Multivalent Pneumococcal Conjugate Vaccine Consumption by Region (2018-2023)
        2.2.2 World Multivalent Pneumococcal Conjugate Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029)
    2.4 China Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029)
    2.5 Europe Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029)
    2.6 Japan Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029)
    2.7 South Korea Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029)
    2.8 ASEAN Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029)
    2.9 India Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029)

3 World Multivalent Pneumococcal Conjugate Vaccine Manufacturers Competitive Analysis
    3.1 World Multivalent Pneumococcal Conjugate Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Multivalent Pneumococcal Conjugate Vaccine Production by Manufacturer (2018-2023)
    3.3 World Multivalent Pneumococcal Conjugate Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Multivalent Pneumococcal Conjugate Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Multivalent Pneumococcal Conjugate Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Multivalent Pneumococcal Conjugate Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Multivalent Pneumococcal Conjugate Vaccine in 2022
    3.6 Multivalent Pneumococcal Conjugate Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Multivalent Pneumococcal Conjugate Vaccine Market: Region Footprint
        3.6.2 Multivalent Pneumococcal Conjugate Vaccine Market: Company Product Type Footprint
        3.6.3 Multivalent Pneumococcal Conjugate Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Multivalent Pneumococcal Conjugate Vaccine Production Value Comparison
        4.1.1 United States VS China: Multivalent Pneumococcal Conjugate Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Multivalent Pneumococcal Conjugate Vaccine Production Comparison
        4.2.1 United States VS China: Multivalent Pneumococcal Conjugate Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Multivalent Pneumococcal Conjugate Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Multivalent Pneumococcal Conjugate Vaccine Consumption Comparison
        4.3.1 United States VS China: Multivalent Pneumococcal Conjugate Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Multivalent Pneumococcal Conjugate Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Multivalent Pneumococcal Conjugate Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Multivalent Pneumococcal Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production (2018-2023)
    4.5 China Based Multivalent Pneumococcal Conjugate Vaccine Manufacturers and Market Share
        4.5.1 China Based Multivalent Pneumococcal Conjugate Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production (2018-2023)
    4.6 Rest of World Based Multivalent Pneumococcal Conjugate Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Multivalent Pneumococcal Conjugate Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Multivalent Pneumococcal Conjugate Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 13 Price
        5.2.2 20 Price
        5.2.3 23 Price
        5.2.4 24 Price
    5.3 Market Segment by Type
        5.3.1 World Multivalent Pneumococcal Conjugate Vaccine Production by Type (2018-2029)
        5.3.2 World Multivalent Pneumococcal Conjugate Vaccine Production Value by Type (2018-2029)
        5.3.3 World Multivalent Pneumococcal Conjugate Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Multivalent Pneumococcal Conjugate Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Outpatient Center
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Multivalent Pneumococcal Conjugate Vaccine Production by Application (2018-2029)
        6.3.2 World Multivalent Pneumococcal Conjugate Vaccine Production Value by Application (2018-2029)
        6.3.3 World Multivalent Pneumococcal Conjugate Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Merck Sharp & Dohme Corp
        7.1.1 Merck Sharp & Dohme Corp Details
        7.1.2 Merck Sharp & Dohme Corp Major Business
        7.1.3 Merck Sharp & Dohme Corp Multivalent Pneumococcal Conjugate Vaccine Product and Services
        7.1.4 Merck Sharp & Dohme Corp Multivalent Pneumococcal Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Merck Sharp & Dohme Corp Recent Developments/Updates
        7.1.6 Merck Sharp & Dohme Corp Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Multivalent Pneumococcal Conjugate Vaccine Product and Services
        7.2.4 Pfizer Multivalent Pneumococcal Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 CanSino Bio
        7.3.1 CanSino Bio Details
        7.3.2 CanSino Bio Major Business
        7.3.3 CanSino Bio Multivalent Pneumococcal Conjugate Vaccine Product and Services
        7.3.4 CanSino Bio Multivalent Pneumococcal Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 CanSino Bio Recent Developments/Updates
        7.3.6 CanSino Bio Competitive Strengths & Weaknesses
    7.4 Serum Institute of India Pvt. Ltd.
        7.4.1 Serum Institute of India Pvt. Ltd. Details
        7.4.2 Serum Institute of India Pvt. Ltd. Major Business
        7.4.3 Serum Institute of India Pvt. Ltd. Multivalent Pneumococcal Conjugate Vaccine Product and Services
        7.4.4 Serum Institute of India Pvt. Ltd. Multivalent Pneumococcal Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
        7.4.6 Serum Institute of India Pvt. Ltd. Competitive Strengths & Weaknesses
    7.5 Shanghai Weizhou Biotechnology Co., Ltd.
        7.5.1 Shanghai Weizhou Biotechnology Co., Ltd. Details
        7.5.2 Shanghai Weizhou Biotechnology Co., Ltd. Major Business
        7.5.3 Shanghai Weizhou Biotechnology Co., Ltd. Multivalent Pneumococcal Conjugate Vaccine Product and Services
        7.5.4 Shanghai Weizhou Biotechnology Co., Ltd. Multivalent Pneumococcal Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Shanghai Weizhou Biotechnology Co., Ltd. Recent Developments/Updates
        7.5.6 Shanghai Weizhou Biotechnology Co., Ltd. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Multivalent Pneumococcal Conjugate Vaccine Industry Chain
    8.2 Multivalent Pneumococcal Conjugate Vaccine Upstream Analysis
        8.2.1 Multivalent Pneumococcal Conjugate Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Multivalent Pneumococcal Conjugate Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Multivalent Pneumococcal Conjugate Vaccine Production Mode
    8.6 Multivalent Pneumococcal Conjugate Vaccine Procurement Model
    8.7 Multivalent Pneumococcal Conjugate Vaccine Industry Sales Model and Sales Channels
        8.7.1 Multivalent Pneumococcal Conjugate Vaccine Sales Model
        8.7.2 Multivalent Pneumococcal Conjugate Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Multivalent Pneumococcal Conjugate Vaccine Production by Region (2018-2023) & (K Units)
    Table 7. World Multivalent Pneumococcal Conjugate Vaccine Production by Region (2024-2029) & (K Units)
    Table 8. World Multivalent Pneumococcal Conjugate Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Multivalent Pneumococcal Conjugate Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Multivalent Pneumococcal Conjugate Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Multivalent Pneumococcal Conjugate Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Multivalent Pneumococcal Conjugate Vaccine Major Market Trends
    Table 13. World Multivalent Pneumococcal Conjugate Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Multivalent Pneumococcal Conjugate Vaccine Consumption by Region (2018-2023) & (K Units)
    Table 15. World Multivalent Pneumococcal Conjugate Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Multivalent Pneumococcal Conjugate Vaccine Producers in 2022
    Table 18. World Multivalent Pneumococcal Conjugate Vaccine Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Multivalent Pneumococcal Conjugate Vaccine Producers in 2022
    Table 20. World Multivalent Pneumococcal Conjugate Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Multivalent Pneumococcal Conjugate Vaccine Company Evaluation Quadrant
    Table 22. World Multivalent Pneumococcal Conjugate Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Multivalent Pneumococcal Conjugate Vaccine Production Site of Key Manufacturer
    Table 24. Multivalent Pneumococcal Conjugate Vaccine Market: Company Product Type Footprint
    Table 25. Multivalent Pneumococcal Conjugate Vaccine Market: Company Product Application Footprint
    Table 26. Multivalent Pneumococcal Conjugate Vaccine Competitive Factors
    Table 27. Multivalent Pneumococcal Conjugate Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Multivalent Pneumococcal Conjugate Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Multivalent Pneumococcal Conjugate Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Multivalent Pneumococcal Conjugate Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Multivalent Pneumococcal Conjugate Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Multivalent Pneumococcal Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Market Share (2018-2023)
    Table 37. China Based Multivalent Pneumococcal Conjugate Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Multivalent Pneumococcal Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Market Share (2018-2023)
    Table 47. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Multivalent Pneumococcal Conjugate Vaccine Production by Type (2018-2023) & (K Units)
    Table 49. World Multivalent Pneumococcal Conjugate Vaccine Production by Type (2024-2029) & (K Units)
    Table 50. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Multivalent Pneumococcal Conjugate Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Multivalent Pneumococcal Conjugate Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Multivalent Pneumococcal Conjugate Vaccine Production by Application (2018-2023) & (K Units)
    Table 56. World Multivalent Pneumococcal Conjugate Vaccine Production by Application (2024-2029) & (K Units)
    Table 57. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Multivalent Pneumococcal Conjugate Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Multivalent Pneumococcal Conjugate Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Merck Sharp & Dohme Corp Basic Information, Manufacturing Base and Competitors
    Table 62. Merck Sharp & Dohme Corp Major Business
    Table 63. Merck Sharp & Dohme Corp Multivalent Pneumococcal Conjugate Vaccine Product and Services
    Table 64. Merck Sharp & Dohme Corp Multivalent Pneumococcal Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Merck Sharp & Dohme Corp Recent Developments/Updates
    Table 66. Merck Sharp & Dohme Corp Competitive Strengths & Weaknesses
    Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 68. Pfizer Major Business
    Table 69. Pfizer Multivalent Pneumococcal Conjugate Vaccine Product and Services
    Table 70. Pfizer Multivalent Pneumococcal Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Pfizer Recent Developments/Updates
    Table 72. Pfizer Competitive Strengths & Weaknesses
    Table 73. CanSino Bio Basic Information, Manufacturing Base and Competitors
    Table 74. CanSino Bio Major Business
    Table 75. CanSino Bio Multivalent Pneumococcal Conjugate Vaccine Product and Services
    Table 76. CanSino Bio Multivalent Pneumococcal Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. CanSino Bio Recent Developments/Updates
    Table 78. CanSino Bio Competitive Strengths & Weaknesses
    Table 79. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
    Table 80. Serum Institute of India Pvt. Ltd. Major Business
    Table 81. Serum Institute of India Pvt. Ltd. Multivalent Pneumococcal Conjugate Vaccine Product and Services
    Table 82. Serum Institute of India Pvt. Ltd. Multivalent Pneumococcal Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
    Table 84. Shanghai Weizhou Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 85. Shanghai Weizhou Biotechnology Co., Ltd. Major Business
    Table 86. Shanghai Weizhou Biotechnology Co., Ltd. Multivalent Pneumococcal Conjugate Vaccine Product and Services
    Table 87. Shanghai Weizhou Biotechnology Co., Ltd. Multivalent Pneumococcal Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 88. Global Key Players of Multivalent Pneumococcal Conjugate Vaccine Upstream (Raw Materials)
    Table 89. Multivalent Pneumococcal Conjugate Vaccine Typical Customers
    Table 90. Multivalent Pneumococcal Conjugate Vaccine Typical Distributors
List of Figure
    Figure 1. Multivalent Pneumococcal Conjugate Vaccine Picture
    Figure 2. World Multivalent Pneumococcal Conjugate Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Multivalent Pneumococcal Conjugate Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Multivalent Pneumococcal Conjugate Vaccine Production (2018-2029) & (K Units)
    Figure 5. World Multivalent Pneumococcal Conjugate Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Multivalent Pneumococcal Conjugate Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Multivalent Pneumococcal Conjugate Vaccine Production (2018-2029) & (K Units)
    Figure 9. Europe Multivalent Pneumococcal Conjugate Vaccine Production (2018-2029) & (K Units)
    Figure 10. China Multivalent Pneumococcal Conjugate Vaccine Production (2018-2029) & (K Units)
    Figure 11. Japan Multivalent Pneumococcal Conjugate Vaccine Production (2018-2029) & (K Units)
    Figure 12. Multivalent Pneumococcal Conjugate Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029) & (K Units)
    Figure 15. World Multivalent Pneumococcal Conjugate Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029) & (K Units)
    Figure 17. China Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029) & (K Units)
    Figure 18. Europe Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029) & (K Units)
    Figure 19. Japan Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029) & (K Units)
    Figure 22. India Multivalent Pneumococcal Conjugate Vaccine Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Multivalent Pneumococcal Conjugate Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Multivalent Pneumococcal Conjugate Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Multivalent Pneumococcal Conjugate Vaccine Markets in 2022
    Figure 26. United States VS China: Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Multivalent Pneumococcal Conjugate Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Multivalent Pneumococcal Conjugate Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Multivalent Pneumococcal Conjugate Vaccine Production Market Share 2022
    Figure 32. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share by Type in 2022
    Figure 34. 13 Price
    Figure 35. 20 Price
    Figure 36. 23 Price
    Figure 37. 24 Price
    Figure 38. World Multivalent Pneumococcal Conjugate Vaccine Production Market Share by Type (2018-2029)
    Figure 39. World Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share by Type (2018-2029)
    Figure 40. World Multivalent Pneumococcal Conjugate Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Multivalent Pneumococcal Conjugate Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share by Application in 2022
    Figure 43. Hospital
    Figure 44. Outpatient Center
    Figure 45. Others
    Figure 46. World Multivalent Pneumococcal Conjugate Vaccine Production Market Share by Application (2018-2029)
    Figure 47. World Multivalent Pneumococcal Conjugate Vaccine Production Value Market Share by Application (2018-2029)
    Figure 48. World Multivalent Pneumococcal Conjugate Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Multivalent Pneumococcal Conjugate Vaccine Industry Chain
    Figure 50. Multivalent Pneumococcal Conjugate Vaccine Procurement Model
    Figure 51. Multivalent Pneumococcal Conjugate Vaccine Sales Model
    Figure 52. Multivalent Pneumococcal Conjugate Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck Sharp & Dohme Corp
Pfizer
CanSino Bio
Serum Institute of India Pvt. Ltd.
Shanghai Weizhou Biotechnology Co., Ltd.

Related Reports

Global Multivalent Pneumococcal Conjugate Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Multivalent Pneumococcal Conjugate Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 05 May 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Multivalent Pneumococcal Conjugate Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Multivalent Pneumococcal Conjugate Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Multivalent Pneumococcal Conjugate Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 18 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Multivalent Pneumococcal Conjugate Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Multivalent Pneumococcal Conjugate Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>